The potential of serum prostate-specific antigen as a predictor of clinical response in patients with lower urinary tract symptoms and benign prostatic hyperplasia.
Roehrborn
C G
CG
Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA. Claus.Roehrborn@UTSouthwestern.edu
D000465:Algorithms; D006801:Humans; D008297:Male; D011467:Prostate / Q000473:pathology*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011470:Prostatic Hyperplasia / Q000097:blood / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome; D016055:Urinary Retention / Q000097:blood / Q000209:etiology
D017430:Prostate-Specific Antigen